Evolent Health, Inc.
EVH
$9.19
-$0.80-8.01%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -8.13% | -25.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.13% | -25.19% | |||
| Cost of Revenue | -9.77% | -33.22% | |||
| Gross Profit | -2.04% | 35.34% | |||
| SG&A Expenses | -2.99% | 63.21% | |||
| Depreciation & Amortization | -3.81% | -17.88% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.39% | -25.53% | |||
| Operating Income | 65.85% | 391.28% | |||
| Income Before Tax | 67.19% | -163.96% | |||
| Income Tax Expenses | -156.12% | 231.13% | |||
| Earnings from Continuing Operations | 69.21% | -183.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 69.21% | -183.39% | |||
| EBIT | 65.85% | 391.28% | |||
| EBITDA | 4.65% | -70.57% | |||
| EPS Basic | 29.62% | -135.44% | |||
| Normalized Basic EPS | 87.14% | -909.97% | |||
| EPS Diluted | 29.62% | -135.44% | |||
| Normalized Diluted EPS | 87.14% | -909.97% | |||
| Average Basic Shares Outstanding | 0.49% | 0.25% | |||
| Average Diluted Shares Outstanding | 0.49% | 0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -2.28% | 0.66% | |||